Bootstrap europe provides successful entrepreneurs with non dilutive funding to help them grow quickly and scale.
Fast growth companies often require additional money to fuel scale, yet their founders and their investors do not want to be diluted. Venture Debt is a way to postpone the next valuation event, and to provide a company with additional time to increase its value prior to a future funding round or an acquisition. The Bootstrap Europe team has supported entrepreneurs and their investors in more than 200 European transactions. Their Venture Debt fund is backed by successful entrepreneurs who in turn are providing a stable source of capital to the next generation of innovators.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
May 15, 2019 | Bootstrap Europe II | €27M |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 17, 2022
Boxy
|
Series A | €25M | Computer Vision | — |
May 25, 2021
Fnatic
|
Series Unknown | $17M | eSports | — |
Feb 8, 2021
Habito
|
Debt Financing | — | Finance | Yes |
Nov 14, 2020
FittingBox
|
Debt Financing | — | Augmented Reality | — |
Nov 14, 2020
M2I Life Sciences
|
Debt Financing | — | Biotechnology | — |
Bootstrap Europe has had 2 exits. Bootstrap Europe most notable exits include Blueprint Genetics , Sequana Medical
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 22, 2020 | Blueprint Genetics | M&A | Biotechnology | Detail |
Feb 11, 2019 | Sequana Medical | IPO | Biotechnology | Detail |